Publication | Closed Access

TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes a single delayed intensification

Hematological MalignancySingle Delayed IntensificationMedicineExcellent PrognosisMixed-phenotype Acute LeukemiaHematologyImmunologyPathologyAdult T-cell Leukemia-lymphomaOncologyTel-aml1 FusionMyeloid Neoplasia